Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Pneumonia? 256 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 256 reports of Pneumonia have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 2.8% of all adverse event reports for CYCLOBENZAPRINE.

256
Reports of Pneumonia with CYCLOBENZAPRINE
2.8%
of all CYCLOBENZAPRINE reports
177
Deaths
117
Hospitalizations

How Dangerous Is Pneumonia From CYCLOBENZAPRINE?

Of the 256 reports, 177 (69.1%) resulted in death, 117 (45.7%) required hospitalization, and 99 (38.7%) were considered life-threatening.

Is Pneumonia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 256 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Pneumonia?

LENALIDOMIDE (14,807) ADALIMUMAB (11,570) RITUXIMAB (11,068) METHOTREXATE (10,278) PREDNISONE (8,472) ETANERCEPT (8,225) DEXAMETHASONE (6,073) INFLIXIMAB (5,885) POMALIDOMIDE (5,792) TOCILIZUMAB (5,484)

Which CYCLOBENZAPRINE Alternatives Have Lower Pneumonia Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Pneumonia Reports All Drugs Causing Pneumonia CYCLOBENZAPRINE Demographics